Staff names and roles have not yet been verified from the company’s official website.
Workforce
Company-wide headcount
Not yet publicly verified
Indiana headcount
Not yet publicly verified
Company-wide, Indiana, local and parent figures are shown separately. Reporting dates may be older than the date checked. Unavailable figures remain unverified.
Quarles & Brady LLP reports that the EEOC has moved to rescind its criminal records (arrest and conviction) guidance, a document central to disparate impact enforcement. The firm advises employers to continue targeted, job‑related screening, avoid blanket and arrest‑only exclusions, apply background check policies consistently, and review state, local, and FCRA obligations. Quarles & Brady notes that while the EEOC may de‑prioritize disparate impact charges, courts and state laws may still enforce disparate impact principles.
Quarles & Brady LLP reports that on October 5 the Supreme Court heard oral argument in Suncor Energy (U.S.A.) Inc. v. County Commissioners of Boulder County concerning whether state tort law may subject fossil-fuel producers to liability for climate harms. Several justices signaled openness to reversing the Colorado Supreme Court, while others identified potential room for state claims. The firm notes jurisdictional questions and a possible Justice Alito recusal as wild cards, and expects the decision to affect energy producers’ exposure to climate-related tort liability.
Quarles & Brady LLP announced that nine people have been elected to the firm’s partnership, the national law firm stated. The announcement appears within the firm’s News & Insights content, indicating this is a firm-issued update about internal leadership changes. The firm presented this election as a formal development in its partnership composition and linked the item to further information for readers.
Quarles & Brady LLP reports that the New Hampshire Board of Pharmacy is considering proposed Part Ph 522 to establish standards for technology-assisted pharmacy practice, explicitly covering AI and clinical decision support. The proposal would allow AI to inform but not replace pharmacist judgment, impose pre-implementation validation, documentation, and vendor-oversight obligations on permit holders, require audit trails (retained generally for at least four years), and mandate periodic reviews. Quarles' Health & Life Sciences Practice Group will monitor developments.
